Join our daily newsletter At The Bell to receive exclusive market insights
- Alcidion Group (ALC) further expands the use of ExtraMed’s IPFM to Queen’s Hospital Burton in England
- IPFM is ExtraMed’s patient flow management software that allows frontline staff to make informed decisions based on real-time visibility of patient flow
- The contract is worth $630,000 over three years and is the first since the acquisition of ExtraMed in April
- Under the agreement, the technology will be used by thousands of staff at Queen’s Hospital Burton, helping them to manage a patient’s journey from admissions and ward transfers through to discharge
- Alcidion was 0.71 per cent up and trading at 35.3 cents per share at 12:53 pm AEDT
Alcidion Group (ALC) has further expanded the use of ExtraMed’s IPFM to Queen’s Hospital Burton in England, following its acquisition in April 2021.
IPFM is ExtraMed’s patient flow management software that allows frontline staff to make informed decisions based on real-time visibility of patient flow.
The technology was successfully deployed at Royal Derby Hospital in 2013, prior to the acquisition.
As a direct results of using the ExtraMed solution, Royal Derby staff have successfully reduced lengths of stay and enhanced care for patients.
University Hospitals of Derby and Burton NHS Foundation Trust (UHDB) will send IPFM the to its Queen’s Hospital Burton, with a total contract value of around $630,000 over three years.
Under the agreement, the technology will be used by thousands of staff at Queen’s Hospital Burton. It will helping staff to manage a patient journey more efficiently across the hospital, from admissions and ward transfers through to discharge.
Director of Nursing at UDHB Gill Ogden said staff were excited about this technology coming to Burton.
“We expect immediate differences for discharge and overall patient flow, with lots more
functionality we will explore over time. Clinical teams at Royal Derby Hospital have really valued having information at a glance and the improved communication that ExtraMed has supported,” he said.
Alcidion was 0.71 per cent up and trading at 35.3 cents per share at 12:53 pm AEDT.
